ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GlaxoSmithKline's Nucala hopes take a hit with FDA panel thumbs-down in COPD
July 27, 2018As would-be rivals struggled with winning FDA approvals in the last few years, GlaxoSmithKline's key respiratory franchise has reaped the benefit. But now, the company is suffering a setback of its own. -
FDA staff question efficacy of GSK’s Nucala for COPD
July 25, 2018US regulatory advisors are questioning the effectiveness of GlaxoSmithKline’s biologic Nucala as a treatment for patients experiencing a sudden worsening of chronic obstructive pulmonary disorder (COPD).
Pharma Sources Insight January 2025
